MAK Capital Updates Agilysys Stake in 13D/A Filing
Ticker: AGYS · Form: SC 13D/A · Filed: Feb 16, 2024 · CIK: 78749
| Field | Detail |
|---|---|
| Company | Agilysys Inc (AGYS) |
| Form Type | SC 13D/A |
| Filed Date | Feb 16, 2024 |
| Risk Level | low |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $82.59 |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-ownership, amendment, institutional-investor
TL;DR
**MAK Capital just updated their Agilysys stake, signaling potential shifts in their investment.**
AI Summary
MAK Capital One LLC, along with its affiliates MAK Capital Distressed Debt Fund I, LP and MAK Capital Fund LP, filed an Amendment No. 23 to their Schedule 13D on February 16, 2024, regarding their ownership in Agilysys, Inc. This filing updates their beneficial ownership of Agilysys, Inc. Common Stock. Michael A. Kaufman is identified as a group member.
Why It Matters
This filing indicates a significant investor, MAK Capital, is updating its position in Agilysys, Inc., which could signal changes in their investment strategy or ongoing engagement with the company.
Risk Assessment
Risk Level: low — This is an amendment to a Schedule 13D, indicating an update to existing ownership information rather than a new, potentially disruptive event.
Key Players & Entities
- MAK Capital One LLC (company) — Filing entity
- Agilysys, Inc. (company) — Subject company
- MAK Capital Distressed Debt Fund I, LP (company) — Group member
- MAK Capital Fund LP (company) — Group member
- Michael A. Kaufman (person) — Group member
FAQ
Who filed this SC 13D/A amendment?
The SC 13D/A Amendment No. 23 was filed by MAK Capital One LLC, along with group members MAK Capital Distressed Debt Fund I, LP, MAK Capital Fund LP, and Michael A. Kaufman.
What is the subject company of this filing?
The subject company of this filing is Agilysys, Inc.
What type of security is involved in this filing?
The security involved is Common Stock, without par value, of Agilysys, Inc.
When was this amendment filed?
This Amendment No. 23 was filed on February 16, 2024.
What is the purpose of an SC 13D/A filing?
An SC 13D/A filing is an amendment to a Schedule 13D, used to report changes in beneficial ownership of 5% or more of a company's outstanding shares by an investor or group.
Filing Stats: 2,392 words · 10 min read · ~8 pages · Grade level 8.9 · Accepted 2024-02-16 21:42:55
Key Financial Figures
- $82.59 — Stock to the Underwriter at a price of $82.59 per share. The shares of Common Stock w
Filing Documents
- agilysys_13da23.htm (SC 13D/A) — 109KB
- ex_1.htm (EX-1) — 60KB
- 0001019056-24-000099.txt ( ) — 171KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned each certify that the information with respect to it set forth in this statement is true, complete and correct. Date: February 16, 2024 MAK CAPITAL ONE L.L.C. By: /s/ Michael A. Kaufman Michael A. Kaufman, Managing Member MAK CAPITAL FUND LP By: MAK GP LLC, general partner By: /s/ Michael A. Kaufman Michael A. Kaufman, Managing Member MAK CAPITAL DISTRESSED DEBT FUND I, LP By: MAK DDF-1 GP, LLC, general partner By: /s/ Michael A. Kaufman Michael A. Kaufman, Managing Member By: /s/ Michael A. Kaufman MICHAEL A. KAUFMAN 8 SCHEDULE A RECENT TRANSACTIONS The following transactions on the open market in the shares of Common Stock were effected by the Reporting Persons since January 15, 2024, the date immediately prior to the date of the Reporting Persons’ last amendment of this Schedule 13D (with the reported price per share being a weighted average): Date Sold Shares Sold Price Per share 1/16/2024 13,356 $ 75.0790 1/17/2024 32,958 $ 75.3912 1/18/2024 87,500 $ 77.6264 1/19/2024 14,426 $ 81.6909 Date Sold MAK Fund Sold MAK CDD Fund Sold 1/16/2024 11,072 2,284 1/17/2024 27,322 5,636 1/18/2024 72,538 14,962 1/19/2024 11,959 2,467 The following transaction pursuant to the Underwriting Agreement in the shares of Common Stock were effected by the Reporting Persons since January 15, 2024, the date immediately prior to the date of the Reporting Persons’ last amendment of this Schedule 13D (with the reported price per share being pursuant to the Underwriting Agreement): Date Sold Shares Sold Price Per share 2/14/2024 867,729 $ 82.59 Date Sold MAK Fund Sold MAK CDD Fund Sold 2/14/2024 718,605 149,124 9